Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Sumatriptan Succinate Patent Expiration

Sumatriptan Succinate was first introduced by Glaxosmithkline in its drug Imitrex on Dec 28, 1992. Other drugs containing Sumatriptan Succinate are Alsuma, Zembrace Symtouch, Sumavel Dosepro, Onzetra Xsail, Zecuity, Imitrex Statdose. 34 different companies have introduced drugs containing Sumatriptan Succinate.


Sumatriptan Succinate Patents

Given below is the list of patents protecting Sumatriptan Succinate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zembrace Symtouch US10537554 Pharmaceutical composition for treating migraine Jan 29, 2036 Tonix Meds
Zembrace Symtouch US11364224 Pharmaceutical composition for treating migraine Jan 29, 2036 Tonix Meds
Zembrace Symtouch US12097183 Pharmaceutical composition for treating migraine Jan 29, 2036 Tonix Meds
Onzetra Xsail US10076614 Nasal delivery devices Oct 20, 2034 Currax
Onzetra Xsail US10478574 Nasal administration Nov 04, 2033 Currax
Zecuity US9327114 User-activated self-contained co-packaged iontophoretic drug delivery system Oct 08, 2032 Teva Branded Pharm
Onzetra Xsail US8978647 Nasal delivery Dec 06, 2030 Currax
Zecuity US8983594 Electronic control of drug delivery system Nov 19, 2030 Teva Branded Pharm
Onzetra Xsail US9649456 Nasal administration Oct 21, 2030 Currax
Onzetra Xsail US8899229 Powder delivery devices Aug 18, 2030 Currax
Onzetra Xsail US8550073 Nasal delivery Oct 22, 2029 Currax
Onzetra Xsail US10076615 Nasal delivery Jul 30, 2029 Currax
Zecuity US8366600 Polyamine enhanced formulations for triptan compound iontophoresis Apr 21, 2029 Teva Branded Pharm
Onzetra Xsail US10722667 Nasal administration Dec 30, 2028 Currax
Onzetra Xsail US8875704 Nasal administration Apr 07, 2028 Currax
Onzetra Xsail US10398859 Nasal delivery devices Dec 19, 2027 Currax
Zecuity US9272137 Transdermal methods and systems for the delivery of anti-migraine compounds Sep 07, 2027 Teva Branded Pharm
Alsuma US7811254 Autoinjector with needle depth adapter Aug 26, 2027 Meridian Medcl
Zecuity US7973058 Transdermal methods and systems for the delivery of anti-migraine compounds Apr 12, 2027 Teva Branded Pharm
Zecuity US8155737 Pharmacokinetics of iontophoretic sumatriptan administration Apr 12, 2027 Teva Branded Pharm
Zecuity US8470853 Transdermal methods and systems for the delivery of anti-migraine compounds Apr 12, 2027 Teva Branded Pharm
Zecuity US8597272 Pharmacokinetics of iontophoretic sumatriptan administration Apr 12, 2027 Teva Branded Pharm
Zecuity US9427578 Pharmacokinetics of iontophoretic sumatriptan administration Apr 12, 2027 Teva Branded Pharm
Onzetra Xsail US10124132 Nasal delivery Mar 06, 2027 Currax
Sumavel Dosepro US7776007 Device for readying a needle free injector for delivery Nov 22, 2026 Endo Operations
Sumavel Dosepro US7901385 Casing Jul 31, 2026 Endo Operations
Onzetra Xsail US11571531 Powder delivery devices Feb 23, 2026 Currax
Sumavel Dosepro US8241243 Needleless injector drug capsule and a method for filling thereof Dec 25, 2025 Endo Operations
Onzetra Xsail US8590530 Nasal delivery devices Sep 15, 2025 Currax
Onzetra Xsail US9108015 Nasal delivery devices Sep 15, 2025 Currax
Onzetra Xsail US7975690 Nasal devices Aug 18, 2025 Currax
Sumavel Dosepro US8287489 Device for readying a needle free injector for delivery Dec 06, 2024

(Expired)

 Endo Operations
Onzetra Xsail US9119932 Nasal delivery device Apr 23, 2024

(Expired)

 Currax
Onzetra Xsail US8327844 Nasal delivery method Oct 03, 2023

(Expired)

 Currax
Sumavel Dosepro US8118771 Needleless injector drug capsule and a method for filling thereof Aug 10, 2023

(Expired)

 Endo Operations
Onzetra Xsail US8047202 Nasal devices Jul 02, 2023

(Expired)

 Currax
Sumavel Dosepro US8267903 Casing Mar 18, 2023

(Expired)

 Endo Operations
Zecuity US6745071 Iontophoretic drug delivery system Feb 21, 2023

(Expired)

 Teva Branded Pharm
Sumavel Dosepro US8241244 Needleless injector drug capsule and a method for filling thereof Nov 21, 2022

(Expired)

 Endo Operations
Sumavel Dosepro US8491524 Needleless injector drug capsule and a method for filling thereof Nov 21, 2022

(Expired)

 Endo Operations
Sumavel Dosepro US8343130 Needleless injector Oct 18, 2022

(Expired)

 Endo Operations
Onzetra Xsail US6715485 Nasal delivery device Mar 03, 2020

(Expired)

 Currax
Onzetra Xsail US8555877 Nasal delivery device Mar 03, 2020

(Expired)

 Currax
Sumavel Dosepro US6280410 Method of filling a drug capsule and article produced thereby Mar 27, 2017

(Expired)

 Endo Operations
Sumavel Dosepro US6135979 Spring-powered dispensing device for medical purposes Mar 21, 2017

(Expired)

 Endo Operations
Sumavel Dosepro US6251091 Needleless injector drug capsule and filling method Dec 09, 2016

(Expired)

 Endo Operations
Sumavel Dosepro US5957886 Spring-Powered dispensing device Mar 08, 2016

(Expired)

 Endo Operations
Sumavel Dosepro US6174304 Filling device for a needless injector cartridge Dec 13, 2015

(Expired)

 Endo Operations
Sumavel Dosepro US6681810 Filling device for a needleless injector cartridge Dec 13, 2015

(Expired)

 Endo Operations
Sumavel Dosepro US5891086 Needle-less injector Jul 27, 2014

(Expired)

 Endo Operations



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sumatriptan Succinate's patents.

Given below is the list recent legal activities going on the following patents of Sumatriptan Succinate.

Activity Date Patent Number
Patent litigations
Expire Patent
Critical
 10 Jun, 2024 US9327114
Email Notification
Critical
 24 Apr, 2024 US10537554
Email Notification
Critical
 24 Apr, 2024 US11364224
Change in Power of Attorney (May Include Associate POA)
Critical
 24 Apr, 2024 US11364224
Change in Power of Attorney (May Include Associate POA)
Critical
 24 Apr, 2024 US10537554
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 15 Apr, 2024 US10537554
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 15 Apr, 2024 US11364224
Maintenance Fee Reminder Mailed
Critical
 25 Dec, 2023 US9327114
Payment of Maintenance Fee, 4th Year, Large Entity 21 Jul, 2023 US10537554
Expire Patent
Critical
 24 Apr, 2023 US8983594


Sumatriptan Succinate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sumatriptan Succinate Generic API Manufacturers

Several generic applications have been filed for Sumatriptan Succinate. The first generic version for Sumatriptan Succinate was by Teva Parenteral Medicines Inc and was approved on Feb 6, 2009. And the latest generic version is by Baxter Healthcare Corp and was approved on Jan 19, 2023.

Given below is the list of companies who have filed for Sumatriptan Succinate generic, along with the locations of their manufacturing plants worldwide.


1. ANTARES PHARMA INC

Antares Pharma Inc has filed for 2 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Antares Pharma Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Dec 10, 2015
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Dec 10, 2015


Manufacturing Plant Locations
New

Antares Pharma Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Antares Pharma Inc as present at those locations.

Country City Firm Name
United States
Ewing Antares Pharma Inc.





2. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 50MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 100MG BASE

tablet Prescription ORAL AB Aug 10, 2009


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





3. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Jan 19, 2023





4. CAPLIN

Caplin Steriles Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Caplin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Jul 13, 2021


Manufacturing Plant Locations
New

Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.

Country City Firm Name
United States
Creve Coeur Caplin, Dr David
India
Gummidipoondi Caplin Steriles Limited





5. COREPHARMA

Corepharma Llc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Prescription ORAL AB Jun 19, 2012
EQ 25MG BASE

tablet Prescription ORAL AB Jun 19, 2012
EQ 100MG BASE

tablet Prescription ORAL AB Jun 19, 2012


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





6. DR REDDYS

Dr Reddys Laboratories Inc has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Prescription SUBCUTANEOUS AB Jan 29, 2014





7. DR REDDYS LABS INC

Dr Reddys Laboratories Inc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 50MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 100MG BASE

tablet Prescription ORAL AB Aug 10, 2009





8. ENDO OPERATIONS

Endo Operations Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Oct 9, 2009





9. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

(reference standard)

injectable Prescription SUBCUTANEOUS AP Apr 23, 2013


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited
Pashamylaram Eugia Pharma Specialities Limited





10. FOSUN PHARMA

Fosun Pharma Usa Inc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Fosun Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009
EQ 50MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009
EQ 100MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009


Manufacturing Plant Locations
New

Fosun Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fosun Pharma as present at those locations.

Country City Firm Name
United States
Princeton Fosun Pharma USA Inc.





11. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Sep 18, 2009
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Sep 18, 2009


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Melrose Park Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC





12. HIKMA

Hikma Farmaceutica Portugal Sa has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Sep 16, 2013


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





13. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Discontinued ORAL N/A May 21, 2013
EQ 25MG BASE

tablet Discontinued ORAL N/A May 21, 2013
EQ 100MG BASE

tablet Discontinued ORAL N/A May 21, 2013





14. MYLAN

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Nov 2, 2009
EQ 50MG BASE

tablet Discontinued ORAL N/A Nov 2, 2009
EQ 100MG BASE

tablet Discontinued ORAL N/A Nov 2, 2009


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Saint Albans Mylan Technologies, Inc.
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Rockford Mylan Institutional, Inc.
Morgantown Mylan Specialty, L.P.
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Greensboro Mylan Pharmaceuticals Inc
India
Sarigam Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Anekal Taluk, Bangalore Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Hosur Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Pithampur, District Dhar Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





15. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Apr 14, 2014





16. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 50MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 100MG BASE

tablet Prescription ORAL AB Aug 10, 2009





17. ROXANE

Roxane Laboratories Inc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009
EQ 50MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009
EQ 100MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009





18. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Feb 6, 2009
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Feb 6, 2009


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





19. STERISCIENCE SPECLTS

Steriscience Specialities Pte Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Steriscience Speclts.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Jul 28, 2010





20. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Prescription SUBCUTANEOUS AB Jun 21, 2011


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Billerica Sun Pharmaceutical Industries, Inc.
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Lexington Sun Pharmaceutical Industries Inc
India
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Punjab Sun Pharmaceutical Industries, Inc.
Vadodara Sun Pharmaceutical Industries Ltd.
Halol Sun Pharmaceutical Industries Ltd.
Dadra Sun Pharmaceutical Industries Limited
Bharuch Sun Pharmaceutical Industries Ltd
Baruch Sun Pharmaceutical Industries Ltd.
Ahmednagar Sun Pharmaceutical Industries Limited
Mohali Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
New Delhi Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd





21. SUN PHARM INDS

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 50MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 100MG BASE

tablet Prescription ORAL AB Aug 10, 2009





22. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 100MG BASE

tablet Discontinued ORAL N/A Feb 9, 2009
EQ 25MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009
EQ 50MG BASE

tablet Discontinued ORAL N/A Aug 10, 2009





23. TEVA

Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 50MG BASE

tablet Discontinued ORAL N/A Feb 9, 2009
EQ 100MG BASE

tablet Discontinued ORAL N/A Feb 9, 2009
EQ 25MG BASE

tablet Discontinued ORAL N/A Feb 9, 2009


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Fort Dodge TEVA Animal Health Inc
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Markham Teva Canada Limited
Stouffville Teva Canada Limited
Scarborough Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





24. TEVA PARENTERAL

Teva Parenteral Medicines Inc has filed for 2 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Teva Parenteral.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Feb 6, 2009
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Feb 6, 2009


Manufacturing Plant Locations
New

Teva Parenteral's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Teva Parenteral as present at those locations.

Country City Firm Name
United States
Irvine Teva Parenteral Medicines, Inc.





25. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Feb 6, 2009





26. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 25MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 50MG BASE

tablet Prescription ORAL AB Aug 10, 2009
EQ 100MG BASE

tablet Prescription ORAL AB Aug 10, 2009





27. WEST-WARD PHARMS INT

West-ward Pharmaceuticals International Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by West-ward Pharms Int.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Feb 6, 2009





28. WOCKHARDT

Wockhardt Ltd has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Prescription SUBCUTANEOUS AP Feb 6, 2009


Manufacturing Plant Locations
New

Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.

Country City Firm Name
India
Ankleshwar Wockhardt, Ltd.
Solan, Nalagarh Wockhardt Limited - Baddi
Aurangabad Wockhardt Limited





29. ZYDUS

Zydus Worldwide Dmcc has filed for 1 generic for Sumatriptan Succinate. Given below are the details of the strengths of this generic introduced by Zydus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

injectable Discontinued SUBCUTANEOUS N/A Aug 11, 2010


Manufacturing Plant Locations
New

Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.

Country City Firm Name
India
Thane Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Ankleshwar Zydus Lifesciences Limited
Matoda Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Matoda, Ahmedabad Zydus Animal Health and Investments Limited
Jarod Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Matoda Zydus Hospira Oncology Private Ltd.
Dabhasa Zydus Lifesciences Limited
United States
Pennington Zydus Pharmaceuticals (USA) Inc